Acquisition History / Kotak Special Situations Fund / Biocon Biologics Limited
Kotak Special Situations Fund Acquires Biocon Biologics Limited
Announced January 2023 — Price not disclosed (CCI combination order)
What happened
Biosimilars business of Biocon Acquired through Kotak Special Situations Fund, a vehicle of Kotak Investment Advisors. Source: https://www.cci.gov.in/images/summaryorders/en/summary1691725241.pdf
- Acquirer
- Kotak Special Situations Fund
- Target
- Biocon Biologics Limited
- Announced
- January 2023
- Price
- Price not disclosed (CCI combination order)
- Industry
- Biopharmaceuticals
- Buyer type
- Private equity
- Fund vehicle
- Kotak Special Situations Fund
- Backing investors
- Kotak Investment Advisors
- Status
- Closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Kotak Special Situations Fund acquire Biocon Biologics Limited?
Kotak Special Situations Fund acquired Biocon Biologics Limited on January 2023. This was Kotak Special Situations Fund's 1st publicly tracked acquisition out of 1 we have on record.
How much did Kotak Special Situations Fund pay for Biocon Biologics Limited?
Kotak Special Situations Fund paid Price not disclosed (CCI combination order) for Biocon Biologics Limited.
What does Biocon Biologics Limited do?
Biosimilars business of Biocon Acquired through Kotak Special Situations Fund, a vehicle of Kotak Investment Advisors. Source: https://www.cci.gov.in/images/summaryorders/en/summary1691725241.pdf
What other Biopharmaceuticals companies has Kotak Special Situations Fund acquired?
Biocon Biologics Limited is Kotak Special Situations Fund's only publicly tracked acquisition in Biopharmaceuticals so far.
More Biopharmaceuticals acquisitions
Servier acquires Muscular dystrophy business of Edgewise Therapeutics Inc.
$2.65B · 2026
Ono Pharmaceutical Co., Ltd. acquires Deciphera Pharmaceuticals, Inc.
$2.40B · 2024
ESOF III Investment Fund acquires Biocon Biologics Limited
Price not disclosed (CCI combination order) · 2023